Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC SNORenz settlement

This article was originally published in The Tan Sheet

Executive Summary

Osteopathic physician Robert Currier barred from representing that Med Gen's SNORenz, other supplement "reduces or eliminates snoring or the sound of snoring in users" and "can eliminate, reduce or mitigate the symptoms of sleep apnea" absent competent and reliable scientific evidence, states an 1FTC consent order released Nov. 5. Currier also is required to issue sleep apnea warning in conjunction with snoring claims made for products not proven to treat apnea. The doctor appeared in SNORenz infomercials that were the subject of two previously approved FTC consent orders against the product's manufacturer and infomercial producer (2"The Tan Sheet" April 2, 2001, p. 6)...
Advertisement

Related Content

SNORenz Research Require Precise Endpoints - FTC
SNORenz Research Require Precise Endpoints - FTC

Topics

Advertisement
UsernamePublicRestriction

Register

PS094760

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel